Cancer incidence and type of treatment hospital among children, adolescents, and young adults in Japan, 2016–2018

Author:

Nakata Kayo12ORCID,Matsuda Tomohiro2ORCID,Hori Megumi3,Sugiyama Hiromi4ORCID,Tabuchi Ken5,Miyashiro Isao1ORCID,Matsumoto Kimikazu6,Yoneda Akihiro78ORCID,Takita Junko9ORCID,Shimizu Chikako10,Katanoda Kota2ORCID

Affiliation:

1. Cancer Control Center Osaka International Cancer Institute Osaka Japan

2. National Cancer Center Institute for Cancer Control Tokyo Japan

3. Department of Nursing University of Shizuoka Shizuoka Japan

4. Department of Epidemiology Radiation Effects Research Foundation Hiroshima Japan

5. Tokyo Cancer Registry, Bureau of Social Welfare and Public Health Tokyo Metropolitan Government Tokyo Japan

6. Children's Cancer Center National Center for Child Health and Development Tokyo Japan

7. Division of Surgery, Surgical Oncology National Center for Child Health and Development Tokyo Japan

8. Division of Pediatric Surgical Oncology National Cancer Center Hospital Tokyo Japan

9. Department of Pediatrics, Graduate School of Medicine Kyoto University Kyoto Japan

10. Department of Breast and Medical Oncology National Center for Global Health and Medicine Tokyo Japan

Abstract

AbstractCancer in children, adolescents, and young adults (AYAs) although rare, is the leading disease‐specific cause of death in Japan. This study aims to investigate cancer incidence and type of treatment hospital among children and AYAs in Japan. Cancer incidence data (2016–2018) for those aged 0–39 years were obtained from the Japanese population‐based National Cancer Registry. Cancer types were classified according to the 2017 update of the International Classification of Childhood Cancer (Third Edition), and AYA Site Recode 2020 Revision. Cases were also categorized into three groups: those treated at core hospitals for pediatric cancer treatment (pediatric cancer hospitals [PCHs]), those treated at designated cancer care hospitals, and those treated at nondesignated hospitals. The age‐standardized incidence rate was 166.6 (per million‐person years) for children (age 0–14 years) and 579.0 for AYAs (age 15–39 years) (including all cancers and benign or uncertain‐behavior central nervous system [CNS] tumors). The type of cancer varied with age: hematological malignancies, blastomas, and CNS tumors were common in children under 10 years, malignant bone tumors and soft tissue sarcomas were relatively common in teenagers, and in young adults over 20 years, carcinomas in thyroid, testis, gastrointestinal, female cervix, and breast were common. The proportion of cases treated at PCHs ranged from 20% to 30% for children, 10% or less for AYAs, and differed according to age group and cancer type. Based on this information, the optimal system of cancer care should be discussed.

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Reference49 articles.

1. International incidence of childhood cancer, 2001–10: a population-based registry study

2. Ministry of Health Labour and Welfare.Vital Statistics of Japan.2022. Accessed July 25 2022.https://www.e‐stat.go.jp/

3. International Classification of Childhood Cancer, third edition

4. National Cancer Institute.Surveillance Epidemiology and End Results (SEER) Program AYA Site Recode.2020. Accessed August 3 2021.https://seer.cancer.gov/ayarecode/

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3